Volume 56, Pages S235-S237 (July 1999)

Slides:



Advertisements
Similar presentations
Ischemic heart disease after renal transplantation
Advertisements

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient  Christoph Wanner,
Anemia management in chronic kidney disease
Volume 61, Issue 6, Pages (June 2002)
Lipopheresis in the nephrotic syndrome
Volume 80, Issue 10, Pages (November 2011)
Progression of renal failure and hypertensive nephrosclerosis
Volume 58, Issue 1, Pages (July 2000)
Volume 70, Pages S21-S25 (December 2006)
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Abnormalities in lipoprotein metabolism in hemodialysis patients
Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 55, Issue 3, Pages (March 1999)
Volume 86, Issue 2, Pages (August 2014)
Reducing lipids for CV protection in CKD patients—current evidence
The epidemiology of chronic kidney disease
Volume 87, Issue 2, Pages (February 2015)
Thomas Quaschning, Jan Galle, Christoph Wanner
Dyslipidemia in children with chronic kidney disease
Edmund G. Lowrie  Kidney International 
Volume 73, Pages S5-S17 (April 2008)
Acute myocardial infarction in patients with end-stage renal disease
Arterial function after successful renal transplantation
Endothelial dysfunction and inflammation: What is the link?
Bone mass evolution after renal transplantation
A physician's perseverance uncovers problems in a key nephrology study
Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?  Lionel Rostaing, Nassim Kamar  Kidney International 
Erratum American Journal of Kidney Diseases
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 60, Issue 1, Pages (July 2001)
Nephrology in Latin America, with special emphasis on Brazil
AGEs in foods: Do they play a role in uremia?
Volume 87, Issue 1, Pages (January 2015)
Volume 56, Pages S137-S140 (July 1999)
Volume 85, Issue 1, Pages 3-4 (January 2014)
Volume 67, Issue 4, Pages (April 2005)
Simvastatin in nephrotic syndrome
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Volume 56, Pages S213-S215 (July 1999)
Mediterranean diets: are they practical in the Western world?
Fabry disease: Diagnosis and treatment
The valuable contribution of observational studies to nephrology
The course of the remnant kidney model in mice
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 56, Pages S71-S74 (November 1999)
Atherosclerotic nephropathy
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Uremic autonomic neuropathy studied by spectral analysis of heart rate
Volume 55, Pages S3-S16 (June 1999)
Erratum American Journal of Kidney Diseases
Volume 65, Issue 2, Pages (February 2004)
Volume 56, Pages S28-S30 (July 1999)
Effect of lipid-lowering strategies on tubular cell biology
Charles A. Herzog  Kidney International 
Volume 56, Pages S254-S255 (July 1999)
Volume 70, Issue 5, Pages (September 2006)
Ischemic heart disease after renal transplantation
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 57, Issue 2, Pages (October 2000)
Lipoprotein abnormalities in diabetic nephropathy
Volume 74, Pages S4-S9 (December 2008)
Volume 62, Issue 5, Pages (November 2002)
Presentation transcript:

Volume 56, Pages S235-S237 (July 1999) Immunosuppression enhances atherogenicity of lipid profile after transplantation  Thomas Quaschning, M.D., Till Mainka, Matthias Nauck, Lars Christian Rump, Christoph Wanner, Annette Krämer-Guth  Kidney International  Volume 56, Pages S235-S237 (July 1999) DOI: 10.1046/j.1523-1755.1999.07162.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Low-density lipoprotein (LDL) triglycerides in male (open bar, N = 201) and female (hatched bar, N = 127) control subjects (Co); male (open bar, N = 16) and female (hatched bar, N = 6) patients on prednisone and azathioprine (A); male (open bar, N = 38) and female (hatched bar, N = 36) patients on prednisone and cyclosporine (B); and male (open bar, N = 81) and female (hatched bar, N = 39) patients on prednisone, azathioprine, and cyclosporine (C). Data are given as mean ± SEM for P < 0.005 (••) vs. controls, and for P < 0.005 (○) vs. (A). Kidney International 1999 56, S235-S237DOI: (10.1046/j.1523-1755.1999.07162.x) Copyright © 1999 International Society of Nephrology Terms and Conditions